Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $6.9350 (-2.05%) ($6.9350 - $7.1700) on Tue. Apr. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 25 | Latest Price | $6.9350(-2.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(66%) IBB(53%) IWC(51%) IWO(46%) IWM(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.105% in a week (0% probabilities). IGOV(-15%) SMH(-14%) VXX(-12%) VIXM(-12%) BNDX(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.23(-204.25%) | Resistance Level | $7.74 | 5 Day Moving Average | $7.13(-2.73%) | 10 Day Moving Average | $7.23(-4.08%) | 20 Day Moving Average | $7.74(-10.4%) | To recent high | -39.3% | To recent low | 0% | Market Cap | $431m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |